Noriyuki Amano

Kanagawa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guérin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective Study.

Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guérin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective Study.

Journal: Urologia internationalis

Published: June 26, 2022

DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer.

DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer.

Journal: Cancers

Published: April 13, 2022

Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer.

Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: March 21, 2022

Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer.

Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer.

Journal: Cancers

Published: February 10, 2022

Patients with Non-Muscle-Invasive Bladder Cancer Previously Treated with Nephroureterectomy Have a High Risk of Recurrence after Bacillus Calmette-Guérin Intravesical Instillation Therapy.

Patients with Non-Muscle-Invasive Bladder Cancer Previously Treated with Nephroureterectomy Have a High Risk of Recurrence after Bacillus Calmette-Guérin Intravesical Instillation Therapy.

Journal: Chemotherapy

Published: January 15, 2022

PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy.

PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy.

Journal: Urologic oncology

Published: August 07, 2020

High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomy.

High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomy.

Journal: Urologic oncology

Published: August 04, 2020

Dermatomyositis-Like Symptoms Useful for Diagnosis of Ureteral Cancer

Dermatomyositis-Like Symptoms Useful for Diagnosis of Ureteral Cancer

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: January 07, 2020

Gleason Pattern 5 is a Possible Pathologic Predictor for Biochemical Recurrence after Laparoscopic Radical Prostatectomy

Gleason Pattern 5 is a Possible Pathologic Predictor for Biochemical Recurrence after Laparoscopic Radical Prostatectomy

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: March 27, 2019

TROY expression is associated with pathological stage and poor prognosis in patients treated with radical cystectomy.

TROY expression is associated with pathological stage and poor prognosis in patients treated with radical cystectomy.

Journal: Cancer biomarkers : section A of Disease markers

Published: November 27, 2018

A Case of Emphysematous Pyelonephritis with Pneumoderma Treated by Open Surgical Drainage

A Case of Emphysematous Pyelonephritis with Pneumoderma Treated by Open Surgical Drainage

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: January 22, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026